US-based research laboratory solution provider VWR has acquired pharmaceutical packaging firm Therapak.
Financial details about the transaction have not been disclosed.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Since 1999, Therapak Corporation and Therapak Pharma Services deliver pre-packaged convenience kits and procedure packs for the clinical trial, pharmaceutical, diagnostic and clinical laboratory industries.
The firm operates via four facilities, two of which are in Los Angeles and Atlanta in the US, and one in London, UK. The fourth one in Singapore was recently set up to expand its business reach across the Asia-Pacific region.
Therapak offers multiple services, including standard and custom component and kit outsourcing, moderate to complex assembly, process control and serial labelling, along with packaging solutions for courier, medical, diagnostic and pharmaceutical products in a variety of temperature-sensitive materials.
VWR Americas lab and distribution services president Mark McLoughlin said: “As a previous supplier to VWR, Therapak has proved to be a leader of procedure and kit assembly, making them a great asset to our organisation.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“We have a similar approach to supporting our customers by understanding customer requirements, then identifying solutions that leverage our knowledge, experience, resources and technology.”
The firm expects the acquisition to boost its range of products and services in order to offer additional solutions to its customers.
